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A commentary on
The Flavonoid Baicalein Rescues Synaptic Plasticity and Memory Deficits in a Mouse Model of 
Alzheimer’s Disease
by Gu XH, Xu LJ, Liu ZQ, Wei B, Yang YJ, Xu GG, et  al. Behav Brain Res (2016) 311:309–21. 
doi: 10.1016/j.bbr.2016.05.052
A recent article by Gu et al. reported that the long-term oral administration of baicalein in mouse, 
inhibited the activity of lipooxygenase 12/15 LXO and glycogen synthase kinase 3β (GSK-3β) in 
hippocampal slices, also reducing the activity of β-secretase enzyme (BACE1) and the concentration 
of total beta-amyloid proteins (Aβ), leading to the in  vivo restoration of spine number, synaptic 
plasticity, and memory deficits (1).
Baicalein (5,6,7-trihydroxy-2-phenyl-chromen-4-one) is present in the plant genus Scutellaria, 
e.g., Scutellaria baicalensis, the flavone recently went in the spotlight for its ability in preventing 
Alzheimer disease (AD) and other neurodegenerative disorders (2–4). According to the authors, 
baicalein is able to prevent the impairment in the hippocampal long-term potentiation (LTP) 
induced by β-amyloids (Aβ) and improve cognitive deficit associated with AD (1). Recently, also 
metformin exhibited positive effects on AD quite comparable to baicalein, i.e., the inhibition of the 
activity of Aβ on LTP in a high fat diet (HFD) rat model (5). As evidence about the anti-obesity 
and anti-diabetes activity of baicalein was reported elsewhere, the activity of metformin may give 
insights on the role exerted by baicalein in AD. Despite the evidence reported by Asadbegi et al. some 
controversial result yet exists, as in type 2 diabetes models metformin increases the expression of the 
β-amyloid precursor protein (APP), through the activation of NF-κB, causing accumulation of Aβ 
in rat brain (5, 6). Whether metformin has either a beneficial or a noxious effect depending on the 
cellular system considered or if it acts through a typical bimodal mechanism, a hallmark shared by 
several bioflavonoids, is yet far to be fully elucidated. As like as flavonoids, even metformin, which 
is a well known anti-diabetic drug, possesses anti-oxidant and anti-inflammatory properties (7). 
This recent evidence suggested us a possible mechanism for baicalein action in AD prevention, as 
also for the flavonoid baicalein, a bimodal activity might be addressed, at least as concern its action 
on oxidative stress and metabolism. The main advantage respect to metformin is that baicalein is 
a plant-derived natural compound. As many bioflavonoids, baicalein inhibits phosphorylation of 
many fundamental signaling protein kinases, leading to its typical anti-inflammatory activity, e.g., it 
inhibits the ERK/MAPK signaling cascade, acting on the phosphorylation of MEK-1 by Raf-1 and 
inducing dampening of NF-κB (8). This anti-phoshorylation property was reported also by Gu et al. 
as baicalein should exert its action by preventing the phosphorylation of tau protein in APP/PS1 
mice (1). Still, a metabolic, anti-oxidant activity from baicalein, besides its targeting glutamatergic 
neurotransmission, may explain some evidence reported (1).
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The authors showed that Aβ binding to synapse-related sites 
mediates the reduction of synaptic loss and also modulates the 
damage of the glutamatergic synaptic transmission, while bai-
calein can prevent this damage (1). Furthermore, the paper by 
Gu et al. would suggest whether the mechanism by which bai-
calein acts on AD may resemble some other neuro-protective 
compound, in order to focus onto commonly shared targets. 
Curiously, as like as metformin, also baicalein succeeded in 
rescuing hippocampal LTP impaired by the action of Aβ and 
the authors suggested a mechanism working through the PI3K 
signaling pathway (1, 5). Further bioflavonoids seem to have 
a comparable effect on the synaptic failure induced by Aβ, 
e.g., the glycosylated-flavonol troxerutin, is able also to reduce 
impairments in cognitive function caused by metabolic syn-
drome or HFD (9, 10) and the flavone nobiletin, from Citrus 
fruit, rescued cognitive function and memory impairment 
in animal fear conditioning tests by reverting the inhibition 
caused by Aβ on the membrane trafficking of glutamate recep-
tors, which is required for LTP (11). And even nobiletin has an 
impact on obesity and metabolic syndrome (12). The question 
is if there is a fundamental connection between metabolic 
syndrome and neurodegenerative disorders in the reported 
action of baicalein.
A possible mechanism linking these effects and shared by 
metformin besides flavonoids might involve their indirect action 
on the impaired insulin signaling and glucose metabolism, 
which causes AD in brain (13). For example, the paper by Gu 
et al. showed that baicalein inhibits the activity of GSK-3β. Brain 
derived insulin is expressed by the activity of the transcription 
factor neurogenic differentiation 1 (NeuroD1) and inhibitors 
of GSK-3β increase insulin gene (Ins2) and NeuroD1 in the 
mouse brain, through a Wnt/β-catenin pathway (14). Gu et  al. 
also reported that baicalein increased the N-methyl-d-aspartate 
glutamate receptor (NMDAR)-mediated LTP in rat hippocam-
pus and it is well known that glutamate, which is spontaneously 
released by astrocytes, is involved in the setting of a LTP threshold 
(15). Therefore, it is possible that an activity of baicalein described 
by Gu et  al. may target the insulin signaling by inhibiting the 
GSK-3β pathway.
The most acknowledged activity of plants bioflavonoids is their 
targeting oxidative stress, gene transcription factors involved 
in the cellular response to oxidative stress and mechanisms 
involved in the scavenging of oxidative stressors. Actually, it is 
not surprising that for the interesting evidence reported by Gu 
et  al. the anti-oxidant property of baicalein might even play a 
major role. For example, the activity of membrane PI3K in astro-
cytes, through the up-regulation of the signaling mechanism, 
involving the activation of phospholipase C and protein kinase 
C-delta (PKC-δ), causes a weak but persistent stimulation of the 
N-methyl-d-aspartate receptors (NMDARs) from astrocytes and 
this mechanism is coupled with the phosphorylation at Thr(395), 
Ser(433), and Thr(439) by PKC-δ of the nuclear factor-(erythroid-
derived 2)-like 2 (Nrf2), then linking glutamate transmission 
with anti-oxidant activity and neuron survival. Translocation 
to the nucleus of Nrf2 enhances the NMDAR stimulation (16). 
Baicalein may target this mechanism, in the system described by 
Gu et al. This should suggest that a possible effect of baicalein may 
be exerted also on the glia, besides neurons, particularly during 
the inflammatory response (17). In this circumstance, further 
research should address the widespread opinion that plant poly-
phenols act on more than one level, fundamentally by targeting 
signaling system that are involved in cell survival and stress 
response. This would involve the existence of complex machinery 
encompassing both homeostasis of the energetic balance and cell 
response to stressors. In this sense, the bio-molecular mechanism 
by which baicalein caused the evidence reported by Gu et al. may 
mainly depend on its anti-oxidant property, as β-secretase 1 
(BACE1) activity, which increases the level of APP, is promoted 
by pro-oxidant factors (18). This potential should shed a light also 
on the neuroprotective role of those natural compounds, which 
are recognized as anti-diabetic and obesity-preventive molecules.
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